InVitria to Attend World Stem Cell Summit

For Immediate Release
9/16/08

Fort Collins, CO-InVitria (www.InVitria.com), a leading global supplier of products that enhance productivity, safety and time to market for companies in the regenerative medicine, cell therapy and life science industry, will take part in the 2008 World Stem Cell Conference, spear-headed by the Genetics Policy Institute, University of Wisconsin-Madison Stem Cell & Regenerative Medicine Center and WiCell Research Institute, Inc., in Madison, WI on September 21-23.
On the internet at: www.worldstemcellsummit.com

Touted as the world's biggest and most informative gathering on the issues surrounding regenerative medicine, the World Stem Cell Summit will host over 150 sponsors, research organizations and media groups.

"InVitria's products have been used to improve performance in a variety of applications in regenerative medicine and tissue engineering," said Scott Deeter, InVitria's President. "We look forward to introducing our products to customers working with stem cell and primary cell culture as well as regenerative medicine."

About InVitria (www.InVitria.com)
InVitria has developed animal free cell culture ingredients that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, life science research and diagnostics industry. InVitria's animal free product line includes:

  • Cellastim - Cellastim is an albumin used to enhance cell growth and productivity. It is animal component free and can readily replace bovine albumin and human albumin as a cell culture ingredient in stem cell media and primary cell media. (see www.Cellastim.com )
  • Lacromin - Lacromin is a growth factor that has unique growth and productivity benefits for stem cell media and primary cell media.
    (see www.Lacromin.com )

For more information about the InVitria line of products, please e-mail This e-mail address is being protected from spambots. You need JavaScript enabled to view it or call 1-800-916-8311.

 
  • Blog: The Cell Culture Dish

    Cell Culture Media supplement Blog Strategies for Improving Viral Yield in Vaccine Manufacturing

    A recent article in Pharma Times titled "US biopharma: nearly 300 vaccines in R&D," points out that there are currently 300 vaccines either in clinical studies or under review by the Food and Drug Administration (FDA). While not all vaccines are cell culture derived vaccines, it does indicate that a large number of cell culture based viral vaccines are in the pipeline and that perhaps viral vaccine manufacturing should be examined. One area under consideration is how to improve viral yield so that vaccines can be made at lower cost ... Read More

  • Latest News

    Invitria Cell Culture Media News InVitria Attends the 13th Bi-Annual Cell Culture Engineering Conference

    March 29, 2012 - InVitria is attending the 13th Bi-Annual Cell Culture Engineering Conference in Scottsdale, Arizona April 22nd through the 27th. This event is an invitation only conference that includes approximately 350 of the world's top academic and industry cell culture scientists. Topics at the conference range from fundamental science to the engineering challenges of cell culture process development.... read more